Evidence map›Paper›PMID 40926638›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026

Optimization of CEST MRI Reporter Protein Design Using Cation-Pi Networks.

David E Korenchan, Ethan J French, Emerenziana Runco, Chetan B Dhakan, Jinwu Yan, Hiroshi Nakashima, Michael T McMahon, Assaf A Gilad, Christian T Farrar

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David E KorenchanAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, 02129, USA.ORCID https://orcid.org/0000-0001-6152-5896
Ethan J FrenchAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, 02129, USA.ORCID https://orcid.org/0000-0002-0418-0489
Emerenziana RuncoDepartment of Neurosurgery, Harvey Cushing Neuro-oncology Laboratories, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Chetan B DhakanAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, 02129, USA.
Jinwu YanAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, 02129, USA.
Hiroshi NakashimaDepartment of Neurosurgery, Harvey Cushing Neuro-oncology Laboratories, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Michael T McMahonF.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, 21205, USA.
Assaf A GiladDepartment of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI, 48824, USA.ORCID https://orcid.org/0000-0002-7272-7570
Christian T FarrarAthinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, 02129, USA.ORCID https://orcid.org/0000-0001-6623-8220

Funding

Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Stewart H Mostofsky · 2020 to 2026
$9.9M
Clinically Translatable MRI Reporter Genes and Imaging Methods with Ultra-High Specificity and SensitivityR01EB031008 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI CHRISTIAN T FARRAR · 2021 to 2026
$4.0M
Evolution and optimization of synthetic <READ/WRITE> function from and into cells using genetic programmingR01EB030565 · NIBIB · MICHIGAN STATE UNIVERSITY · PI BANZHAF, WOLFGANG, GILAD, ASSAF A · 2021 to 2024
$2.3M
Semi-synthetic, magneto-photonic circuit for non-invasive control of cellular functionR01EB031936 · NIBIB · CENTRAL MICHIGAN UNIVERSITY · PI GILAD, ASSAF A, HOCHGESCHWENDER, UTE H · 2021 to 2021
$2.0M
A CEST-MRI Reporter Gene for Image Guided Oncolytic VirotherapyR01CA203873 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FARRAR, CHRISTIAN T · 2016 to 2020
$1.9M
Upgrade of Console for 600 MHz MR SpectrometerS10OD023406 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CHENG, LEO L · 2017 to 2017
$600k
Massachusetts Life Sciences CenterNCI NIH HHS R01 CA203873NCI NIH HHS R01-CA203873NIBIB NIH HHS R01 EB030565NIBIB NIH HHS R01-EB030565NIBIB NIH HHS R01 EB031008NIBIB NIH HHS R01-EB031008NIBIB NIH HHS R01 EB031936NIBIB NIH HHS R01-EB031936NICHD NIH HHS P50 HD103538NIH HHS S10 OD023406NIH HHS S10-OD023406
6 · The paper itself

Abstract

Nucleic acid-based therapeutics, such as oncolytic virotherapy or gene therapy, would benefit greatly from a reporter gene that induces endogenous production of a protein biomarker to noninvasively track the delivery, persistence, and spread with imaging. Several chemical exchange saturation transfer (CEST) reporter proteins detectable by magnetic resonance imaging (MRI) have been demonstrated to have high sensitivity. However, to date none can provide strong CEST contrast at a distinct resonance from that of endogenous proteins, limiting their specificity. We investigated proteins and peptides containing tyrosine (Tyr), tryptophan (Trp), and lysine (Lys) residues that demonstrate CEST contrast shifted far downfield (4-10 ppm) from water. Although Tyr, Trp, and Lys exchangeable protons are typically not detectable under physiological conditions, those in our tested molecules are, having exchange rates of 400-2500 s

Indexed as

CationsContrast MediaMagnetic Resonance ImagingPeptidesProteinsGenes, ReporterHydrogen BondingLysineTryptophanTyrosineCationsContrast MediaLysinePeptidesProteinsTryptophanTyrosinecation‐pi interactionchemical exchange saturation transfermagnetic resonance imagingnuclear magnetic resonance spectroscopyreporter proteins

Identifiers

PMID40926638
PMCPMC13411488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.